THE ULTIMATE GUIDE TO RO5256390

quinupristin/dalfopristin will increase the amount or influence of avanafil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. CYP3A4 inhibitors could decrease avanafil clearance growing systemic publicity to avanafil; elevated ranges may bring about greater affiliated adverse events; the utmost advised dose of STE